IB
CYTK icon

Intrust Bank’s Cytokinetics CYTK Stock Holding History

Intrust Bank’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$540K Buy
6,334
+1,194
+23% +$85.7K 0.04% 258
2026
Q1 		$339K Sell
5,140
-29
-0.6% -$1.84K 0.03% 332
2025
Q4 		$328K Buy
5,169
+616
+14% +$38.3K 0.03% 320
2025
Q3 		$250K Buy
+4,553
New +$188K 0.02% 362
2022
Q4 		– Sell
-4,163
Closed -$202K – 381
2022
Q3 		$202K Buy
+4,163
New +$200K 0.03% 361

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Intrust Bank's CYTK Position: Q2 2026 in Review

Intrust Bank increased its Cytokinetics (CYTK) stake by 23% in Q2 2026, buying an estimated $85.7K and bringing the position to 6,334 shares worth $540K. The position accounts for 0.04% of the portfolio, ranked #258.

Intrust Bank first reported a position in CYTK in Q3 2022 and has held it in 5 quarters since. 484 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Intrust Bank held 6,334 shares of Cytokinetics worth $540K as of Q2 2026.
  • Intrust Bank bought 1,194 Cytokinetics shares in Q2 2026, an estimated $85.7K.
  • Cytokinetics made up 0.04% of Intrust Bank's portfolio in Q2 2026, its #258 holding.
  • Intrust Bank first reported a position in Cytokinetics in Q3 2022 and has held it in 5 quarters since.
  • 484 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Intrust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.